Inhibitex

Polymerase inhibitor for the treatment of Hep C.

placeAlpharetta, Georgia, United States calendar_todayFounded 1994 groups34 employees language inhibitex.com

Registered entities

Innovation

29 patent families (16 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace dormant. Cited 875 times.

YearFilings
201213
20138
20146
20152
20163
20171

Investor mix

10 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital660%
Private equity220%
Bank & private debt110%
Other / undisclosed110%
Coming soon